Benzinga | Oct 28, 2020 12:39PM EDT

Craig-Hallum Initiates Coverage On Processa Pharmaceuticals with Buy Rating, Announces Price Target of $12

Craig-Hallum initiates coverage on Processa Pharmaceuticals (NASDAQ:PCSA) with a Buy rating and announces Price Target of $12.